| abstract |
The invention provides antibodies that specifically bind to LAG-3 (eg, human LAG-3) and antagonize LAG-3 function. Also provided are pharmaceutical compositions comprising the antibodies, nucleic acids encoding the antibodies, expression vectors and host cells for preparing the antibodies, and methods of treating subjects using the antibodies. |